SPHERE GENE THERAPEUTICS Trademark

Trademark Overview

On Friday, May 13, 2022, a trademark application was filed for SPHERE GENE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SPHERE GENE THERAPEUTICS trademark a serial number of 97410265. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, February 27, 2024. This trademark is owned by Sphere Gene Therapeutics Inc.. The SPHERE GENE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations, namely, gene therapies based on engineered viral vectors, for preventing, managing and treating diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Biological components in the nature of enveloped or membrane-associated viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components in the nature of engineered viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, viral vectors, being a component in therapeutic preparations for use in diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Therapeutic agents and gene therapies based on engineered viral vectors for the treatment of diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous system

Research and development in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing scientific testing services in the medical fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing medical scientific research information in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors
sphere gene therapeutics

General Information

Serial Number97410265
Word MarkSPHERE GENE THERAPEUTICS
Filing DateFriday, May 13, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological preparations, namely, gene therapies based on engineered viral vectors, for preventing, managing and treating diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Biological components in the nature of enveloped or membrane-associated viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components in the nature of engineered viral vectors used for the delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, viral vectors, being a component in therapeutic preparations for use in diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous systems; Therapeutic agents and gene therapies based on engineered viral vectors for the treatment of diseases and disorders of the liver, heart, skeletal muscle, ear, eye, peripheral and central nervous system
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing scientific testing services in the medical fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors; Providing medical scientific research information in the fields of gene therapy based on engineered viral vectors, enveloped or membrane-associated viral vectors and engineered viral vectors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSphere Gene Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 27, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, February 27, 2024SUSPENSION LETTER WRITTEN
Tuesday, January 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 6, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 6, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 14, 2023NON-FINAL ACTION E-MAILED
Friday, July 14, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023ASSIGNED TO EXAMINER
Wednesday, May 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 17, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics gene sphere vectors viral engineered based membrane therapeutic associated biological enveloped